Align Technology, Inc.

ALGN · Nasdaq · ·

Comparar

US$ 168,35+0,8%fechamento 13 de nov.

Números até 30 de setembro de 2026, do 10-Q arquivado em 4 de novembro de 2026

1W: +1,4%
1M: +16,6%

Just reported

Q3 2026 results

From Align Technology's results release of 28 de outubro de 2026; its quarterly report has since been filed.

Revenue
Actual
US$ 1,01B
+1,9% y/y
-3,9% q/q
Guided
US$ 1,01B
midpoint
Within guide+0,5%
EPS, GAAP
Actual
US$ 1,90
+144% y/y
+26% q/q
Guided
—
No guide given
Operating income, GAAP
Actual
US$ 169,2M
+76% y/y
+9,8% q/q
Guided
—
No guide given

Company outlook

Q4 2026

RevenueUS$ 1B – US$ 1,02B-3,6% y/y First given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Align Technology is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Curadoria
Medical devices
Por InspectStocks · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
Preço, 1 ano
+6,2%
Receita, 1 ano
+7,2%
+14
A 8B 7C 3D 2

Highest-graded in Medical Instruments and Supplies

Graded A or B and worth $2B or more: A first, then the largest.

All 49 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Demonstrações financeiras completas →

Construído a partir dos próprios documentos de Align Technology, Inc. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.

Align Technology, Inc.

Align Technology, Inc.

Q3 2026 results

Revenue

EPS, GAAP